Search
Search Results
##search.searchResults.foundPlural##
-
ALLOGENEIC TRANSPLANTATION FOR CHRONIC LYMPHOCYTIC LEUKEMIA
1476PDF: 844HTML: 1032 -
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1783PDF: 770HTML: 242 -
HOMOZYGOUS DELETION ALFA-THALASSEMIA AND HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN, TWO GENETIC FACTORS PREDICTIVE THE REDUCTION OF MORBIDITY AND MORTALITY DURING PREGNANCY IN SICKLE CELL PATIENTS . A REPORT FROM DEMOCRATIC REPUBLIC OF CONGO ALPHA THALASSEMIA AND HEREDITARY PERSISTENCE OF FETAL HEMOGLOBIN REDUCE MORBIDITY DURING PREGNANCY IN SICKLE CELL PATIENTS
10644PDF: 1023HTML: 306 -
INFECTIONS AND FOLLICULAR LYMPHOMA: IS THERE A LINK?
3364PDF: 1081HTML: 2405 -
Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated Acute Myeloid leukemia- A case report and review of literature
2099PDF: 980HTML: 1776Sorafenib induced Hand Foot Skin Rash in FLT3 ITD mutated AML- IMAGES: 191 -
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE
2707PDF: 1009HTML: 15136 -
FASTING PLASMA GLUCOSE LEVELS WITHIN THE HIGH NORMAL RANGE ARE ASSOCIATED WITH A SIGNIFICANTLY INCREASED RISK OF FUTURE DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β THALASSEMIA: A DECADE-LONG MULTICENTER RETROSPECTIVE ANALYSIS Higher normal fasting plasma glucose and glucose dysregulation in β- thalassemia
811PDF: 302Html: 39 -
Parasitic hypereosinophilia in childhood: a diagnostic challenge
2666PDF: 854HTML: 380Figure 1: 197 -
EFFECTS OF FACTOR XIII DEFICIENCY ON THROMBOELASTOGRAPHY. THROMBELASTOGRAPHY WITH CALCIUM AND LYSIS BY ADDITION OF STREPTOKINASE IS MORE SENSITIVE THAN SOLUBILITY TESTS
3195PDF: 1022HTML: 1953Untitled: 190Untitled: 210Untitled: 192Untitled: 211Untitled: 195 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3803PDF: 939HTML: 6880 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2575HTML: 310PDF: 949 -
Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients
821PDF: 588HTML: 286 -
VIRAL HEPATITIS A TO E IN SOUTH MEDITERRANEAN COUNTRIES
1310PDF: 683HTML: 7767 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
3051PDF: 1066HTML: 1463 -
How I treat acute and persistent sickle cell pain
2078PDF: 1161HTML: 724 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1238PDF: 867HTML: 2193Figue 1: 194 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8251PDF: 4455HTML: 7566 -
-
THERAPY-RELATED MYELOID NEOPLASMS: CONSIDERATIONS FOR PATIENTS’ CLINICAL EVALUATION. Clinical Evaluation of T-AML
2094PDF: 872HTML: 258 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3441PDF: 1291HTML: 8397 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2290PDF: 1671HTML: 615 -
Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required.
1459PDF: 904HTML: 10097cover letter to the editor: 192tile page: 274 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
769PDF: 484HTML: 6286 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3730PDF: 2605HTML: 1637 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1807PDF: 1342HTML: 638 -
THE BIOLOGY OF MYCOBACTERIUM TUBERCULOSIS INFECTION.
10897PDF: 6530HTML: 21954







